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Biocompatible magnetic core–shell
nanocomposites for engineered magnetic tissues†
Laura Rodriguez-Arco,*a,b Ismael A. Rodriguez,b,c Victor Carriel,b,c
Ana B. Bonhome-Espinosa,a,b Fernando Campos,b,c Pavel Kuzhir,d
Juan D. G. Durana,b and Modesto T. Lopez-Lopez*a,b
The inclusion of magnetic nanoparticles into biopolymer matrixes enables the preparation of magnetic
ﬁeld-responsive engineered tissues. Here we describe a synthetic route to prepare biocompatible core–
shell nanostructures consisting of a polymeric core and a magnetic shell, which are used for this purpose.
We show that using a core–shell architecture is doubly advantageous. First, gravitational settling for core–
shell nanocomposites is slower because of the reduction of the composite average density connected to
the light polymer core. Second, the magnetic response of core–shell nanocomposites can be tuned by
changing the thickness of the magnetic layer. The incorporation of the composites into biopolymer
hydrogels containing cells results in magnetic ﬁeld-responsive engineered tissues whose mechanical pro-
perties can be controlled by external magnetic forces. Indeed, we obtain a signiﬁcant increase of the
viscoelastic moduli of the engineered tissues when exposed to an external magnetic ﬁeld. Because the
composites are functionalized with polyethylene glycol, the prepared bio-artiﬁcial tissue-like constructs
also display excellent ex vivo cell viability and proliferation. When implanted in vivo, the engineered tissues
show good biocompatibility and outstanding interaction with the host tissue. Actually, they only cause a
localized transitory inﬂammatory reaction at the implantation site, without any eﬀect on other organs.
Altogether, our results suggest that the inclusion of magnetic core–shell nanocomposites into biomater-
ials would enable tissue engineering of artiﬁcial substitutes whose mechanical properties could be tuned
to match those of the potential target tissue. In a wider perspective, the good biocompatibility and mag-
netic behavior of the composites could be beneﬁcial for many other applications.
Introduction
The assembly of nanoparticles of diﬀerent materials in hybrid
core–shell nanostructures has become increasingly attractive
in recent years. Such nano-platforms aim to integrate the
specific characteristics of each material into a single, multi-
functional entity, capable of delivering a wide range of fea-
tures.1,2 Potential applications of core–shell composites com-
prise heterogeneous catalysis, energy conversion, water
remediation, optoelectronics and biomedical applications.2–5
In the particular case of biomedical applications, a precise
temporospatial control of the nanocomposites in a minimally
invasive way is tremendously advantageous. In this regard,
magnetic nanoparticles (MNPs) can be integrated into the
nanostructures to provide this feature, located either at the
core of the core–shell architecture or forming the external
shell.6,7 Because of their magnetic nature, MNPs can be
guided by non-contact forces (i.e., external magnetic field gra-
dients), and allow, at the same time, in situ monitoring by
magnetic resonance imaging (MRI) or computerized axial
tomography scanning (CT). Furthermore, their particulate charac-
ter and high surface area make it possible to bind molecules such
as tissue or tumor-specific antibodies, drugs, diagnostic mole-
cules, growth factors, peptides, etc.7–9 As for tissue engineering
applications, MNPs have been previously dispersed in biopoly-
mer matrixes to synthesize innovative artificial magnetic
scaﬀolds without aﬀecting cell adhesion, proliferation or
diﬀerentiation.10–26 Such artificial tissues also possess the
unique feature of being eﬀectively magnetized by the appli-
cation of external fields, and thus, they may attract functiona-
lized MNPs carrying growth factors, drugs or cells.11,17,22
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In all these previous studies reporting magnetic scaﬀolds,
the size of the MNPs was around 10 nm. Nevertheless, the use
of MNPs larger than 50–100 nm has additional advantages
from the magnetic point of view, because the magnetic inter-
action energy between large MNPs dominates over Brownian
motion.27 Actually, the mechanical properties of dispersions of
large MNPs typically used in materials science (e.g., suspen-
sions, gels, foams) can be changed in a reversible way by the
application of an external magnetic field.27–29 In a recent work
we have explored such a phenomenon in the case of novel
magnetic substitutes generated by tissue engineering consist-
ing of solid MNPs of around 100 nm, to show that it is possible
to tune, in a reversible way, their mechanical response by exter-
nal magnetic forces.30
However, the colloidal stability of large magnetic particles
is usually rather poor because they tend to settle due to gravita-
tional forces. Such a problem may be partially overcome if
magnetic core–shell nanocomposites are employed instead.
Indeed, if the material of the core has low density (e.g., poly-
meric core), gravitational settling is much slower because of
the reduction of the composite average density. In addition,
the distribution of the MNPs around a non-magnetic core also
has advantages in terms of the magnetic response of the com-
posite particle. Indeed, in a previous study we have shown that
for a given volume fraction of magnetic material, such a distri-
bution leads to higher magnetic susceptibility at low to
medium magnetic fields than in the case of solid particles,
which means stronger responses to external fields.31
In this work we report new biocompatible magnetic core–
shell nanostructures (diameter ∼500 nm) which are tested for
the generation of magnetic bio-artificial tissue-like constructs.
These nanocomposites consist of a polymeric core and a shell
of MNPs. In addition, biocompatibility is achieved by an
additional layer of polyethylene glycol. We characterize the
composites from the physicochemical point of view (mor-
phology, composition and magnetic properties) and compare
them with solid particles (i.e., no core–shell structure). We also
analyze their ex vivo and in vivo biocompatibility and use them
to generate engineered magnetic tissues, which also exhibit an
active cell proliferation and good in vivo biocompatibility.
We finally evaluate the mechanical properties of the prepared
engineered tissues and test if it is possible to tune them by the
application of external magnetic fields. In addition, we
compare the mechanical properties with those of the engin-
eered tissues prepared with solid particles of our previous
work,30 to show that using a core–shell architecture is highly
advantageous to obtain stronger magnetic field-responsiveness
in these novel biomaterials.
Results and discussion
Synthesis and characterization of magnetic nanocomposites
We prepared biocompatible magnetic core–shell composites
following a two-step procedure as schematized in Fig. 1: (i)
in situ deposition of MNPs around a polymer core (Poly@Mag
composites), and (ii) coating of the resulting nanostructures
with polyethylene glycol (PEG), which was used to impart to
them the necessary biocompatibility to be incorporated into
bio-artificial tissue-like constructs (Poly@Mag@PEG compo-
sites). Indeed, coating nanoparticles with a PEG layer reduces
the attack by macrophages as shown in previous studies.32–34
The composite cores were copolymer spheres of acrylic mono-
mers functionalized with carboxylic, COOH groups (Poly). We
first dispersed the cores in water at pH ∼ 10 to promote de-
protonation of COOH and therefore, to generate negative
surface charge. We then added Fe2+ and Fe3+ solutions (molar
ratio [Fe3+]/Fe2+] = 0.5). Because of their opposite charge, Fe2+
and Fe3+ cations were electrostatically attracted to the core
surface. Once adsorbed, we used an alkali solution to induce
co-precipitation of iron oxide MNPs (a black precipitate
appeared). For PEG coating we adapted the method proposed
in ref. 35, which is based on the formation of an emulsion. We
labelled these composites as Poly@Mag@PEG.
Stage (i) of the synthetic procedure resulted in the polymer
cores fully and homogeneously coated with MNPs. More
specifically, the smooth surface of the core (Fig. 2a and b)
appeared completely covered with MNPs of a diameter of
10–50 nm as shown by scanning (SEM) and transmission
(TEM) electron microscopy (see Fig. 2c and S1 of the ESI,† and
2d respectively). Energy-dispersive X-ray spectroscopy (EDX)
revealed iron as the predominant material of the outer shell
(not shown). The Fourier transform infrared spectroscopy
(FTIR) spectra of Poly@Mag composites also exhibited the
Fig. 1 Sketch of the procedure for magnetic core–shell nanostructure synthesis. In a ﬁrst step, spheres of acrylic copolymers functionalized with
COO− groups (Poly) were used as cores for electrostatic adsorption of Fe2+ and Fe3+ cations, and subsequent surface deposition of MNPs via co-
precipitation under alkaline conditions. The resulting nanocomposites (Poly@Mag) were covered with polyethylene glycol (PEG) in a second step,
using a previous procedure35 based on emulsion formation and yielding Poly@Mag@PEG composites.
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characteristic Fe–O band at 590–630 cm−1 confirming the
presence of iron oxide in the nanocomposites (see Fig. S2
of the ESI†).36 Similarly, thermogravimetric analysis (TGA)
showed a residual weight of inorganic material at high
temperature associated with the MNPs of the shell (see Fig. S3
of the ESI†).
The obtained core–shell structures were uniform in size.
The average diameter varied depending on the employed con-
centration of iron precursors with respect to polymer cores:
higher concentrations of precursors yielded thicker MNP coat-
ings. For example, doubling the concentration of iron cations
from [Fe3+] = 0.3 mM and [Fe2+] = 0.6 mM to [Fe3+] = 0.6 mM
and [Fe2+] = 1.2 mM resulted in an increase of Poly@Mag
diameter from 830 ± 100 nm to 950 ± 70 nm (Fig. 2e). This
result confirms the possibility of tuning the thickness of
the magnetic shell, as shown in previous studies.37,38 However,
a further double increase of the concentration did not yield
a higher diameter, but a rather broader size distribution
(Fig. 2e).
The synthesized composites were ferromagnetic with a
tunable response to the external magnetic field. The co-
precipitation reaction yielded magnetite (Fe3O4), which likely
oxidized to maghemite (γ-Fe2O3) in the presence of oxygen,39
because the X-ray diﬀraction (XRD) spectrum of the nano-
composites could be fitted by both patterns (see Fig. S4 of the
ESI†). The saturation magnetization of γ-Fe2O3 and Fe3O4 is
similar (380 and 480 kA m−1 respectively).40 The saturation
magnetization of our composites was as high as Ms = 150
kA m−1 for the samples with a higher content of the magnetic
material (40 vol%) (Fig. 3a). The magnetization curves were
reversible with almost negligible values of coercivity, rema-
nence, or hysteresis, suggesting nearly superparamagnetic
behaviour (Fig. 3a).
However, the most significant advantage of using core–shell
nanostructures with respect to solid magnetic particles is the
possibility of customizing the initial magnetic susceptibility of
the particles (χi) by changing the thickness of the magnetic
shell. Actually, classical electromagnetism predicts higher χi as
the thickness of the shell becomes thinner, for a given amount
of magnetic material.41,42 To test this for our nanocomposites
we first normalized the magnetization of the samples by divid-
ing it by the saturation magnetization (i.e., M/Ms), so we could
compare them in conditions of an equal concentration of the
magnetic material. We then plotted this normalized magneti-
zation against the magnetic field and compared the initial
slope of the curves, (i.e., the magnetic susceptibility). We con-
firmed that composites with smaller diameters (i.e., thinner
magnetic shells) showed higher χi (Fig. 3b). Furthermore, the
susceptibilities at low to medium fields of the core–shell nano-
structures were always higher than the susceptibility of solid
magnetite particles of diameter of the same order of magni-
tude, previously prepared in our group43 (Fig. 3b).
In addition to higher χi, our nanocomposites showed better
stability against gravitational settling than solid particles.
Indeed, for Poly@Mag samples, the absorbance (A) was
reduced because of settling to a third of its initial value (A0)
only after 24 h. For solid magnetite nanoparticles of similar
size, such a reduction of absorbance took place in less than
1 h (see Fig. 3c).44 Such a better colloidal stability for our nano-
composites was due to their lower average density because of
the lighter polymer core (density ∼1 g cm−3). This feature is
highly advantageous for biomedical applications (e.g., prepa-
Fig. 2 Size and morphology of Poly@Mag composites. Scanning (a and c) and transmission (b and d) electron microscopy photographs of the
polymer core, Poly (a and b), and of Poly@Mag (c and d) composites (bar length = 500 nm). As observed, the cores appeared fully coated with MNPs
of around 10–50 nm diameter. (e) Size distribution of Poly particles and Poly@Mag composites for diﬀerent concentrations of iron precursors. In
general, higher concentrations of precursors yielded thicker MNP coatings.
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ration of magnetic artificial tissues), for which a good dis-
persion of the magnetic composites in the continuous
medium is essential.
The magnetic nanostructures were successfully coated with
PEG (stage (ii) in the sketch of Fig. 1), showing excellent
chemical stability and biocompatibility. The successful PEG
coating was evidenced by the appearance of new bands in the
FTIR spectra corresponding to the in-plane C–H and O–H
deformations and of the combination bands of O–C–H and
C–O–H (see Fig. S2 of the ESI†). It also gave rise to an
additional loss of weight in comparison with Poly@Mag com-
posites in TGA (see Fig. S3 of the ESI†). The PEG shell
appeared as a translucent thin film (thickness of a few nano-
meters) around the magnetic shell in TEM images (Fig. 4a
and S5 of the ESI†). In spite of its small thickness, the PEG
layer protected the magnetic core from mild acidic attack.
Actually, Poly@Mag nanospheres lost their magnetic character
after immersion in HCl (0.1 M) for 7 days (Fig. 4b), while
Poly@Mag@PEG composites were not significantly aﬀected
(Fig. 4c). In addition to better chemical stability, the PEG
coating improved the biocompatibility of the composites.
Human gingival fibroblasts cultured in the presence of
Poly@Mag composites showed substantial morphology altera-
tions. While some of them maintained the typical elongated
spindle shape of fibroblasts, others appeared to have a more
irregular and rounded morphology (Fig. 4f). These latter
results were similar but not comparable to those observed in
the negative control group of cells cultured in the presence of
malign agents (Fig. 4e). Actually, quantitative analysis of DNA
release showed no significant diﬀerences (p > 0.05) for the
Poly@Mag group as compared to the positive control group
(cells growth under normal conditions) (Fig. 4h). These results
suggested that Poly@Mag composites just altered cell attach-
ment to the culture flask, but not the cell membrane per-
meability (cytoplasmic and nuclear), which evidenced the
absence of irreversible cell damage. Interestingly, the WST-1
cell viability assay revealed significant diﬀerences (p < 0.05) in
the cells exposed to Poly@Mag as compared to the positive
Fig. 3 Special features of magnetic core–shell nanostructures. (a) Magnetization, M, plotted against the magnetic ﬁeld, H, for core–shell composites
with diﬀerent concentrations of the magnetic material, ϕ (indicated). As observed, samples with higher magnetic contents displayed higher values of
the saturation magnetization. (b) Normalized magnetization (M/Ms) vs. the magnetic ﬁeld, H, for core–shell nanocomposites of diﬀerent diameters
(indicated). Thicker magnetic coatings gave rise to lower values of the magnetic susceptibility at low-medium ﬁelds (slope of the curve). The suscepti-
bility for solid magnetite nanoparticles with diameter of the same order of magnitude was even lower (reprinted from S. A. Gómez-Lopera, R. C. Plaza
and A. V. Delgado, Synthesis and Characterization of Spherical Magnetite/Biodegradable Polymer Composite Particles, J. Colloid Interface Sci., 240,
40–47, Copyright (2001), with permission from Elsevier43). (c) Absorbance at 550 nm, A, normalized by the value at the beginning of the test, A0, as a
function of time for core–shell nanocomposites and for solid particles (adapted with permission from S. A. Gómez-Lopera, J. L. Arias, V. Gallardo and
A. V. Delgado, Langmuir, 2006, 22, 2816. Copyright (2006) American Chemical Society44). A signiﬁcant reduction of the absorbance (i.e., A/A0 = 0.3)
was only obtained after 24 h for the core–shell structures, in comparison with the fast reduction observed for solid particles.
Paper Nanoscale
Nanoscale This journal is © The Royal Society of Chemistry 2016
O
pe
n 
A
cc
es
s A
rti
cl
e.
 P
ub
lis
he
d 
on
 1
1 
M
ar
ch
 2
01
6.
 D
ow
nl
oa
de
d 
on
 0
2/
04
/2
01
6 
21
:1
0:
29
. 
 
Th
is 
ar
tic
le
 is
 li
ce
ns
ed
 u
nd
er
 a
 C
re
at
iv
e 
Co
m
m
on
s A
ttr
ib
ut
io
n-
N
on
Co
m
m
er
ci
al
 3
.0
 U
np
or
te
d 
Li
ce
nc
e.
View Article Online
control group (Fig. 4i). However, both quantitative analyses
(DNA analysis and WST-1) showed no significant diﬀerences
(p > 0.05) between the fibroblasts cultured in the presence of
Poly@Mag@PEG particles and those cultured under normal
conditions, i.e. positive control (Fig. 4h and i). Actually, these
cells preserved the elongated morphology (Fig. 4g) and were
almost identical to those of the positive control sample of
natural proliferation (Fig. 4d). These results support the high
ex vivo biocompatibility associated with the PEG coating,
which makes Poly@Mag@PEG composites excellent candi-
dates to be included in engineered tissue substitutes.
Preparation and characterization of magnetic tissue
substitutes
We successfully incorporated Poly@Mag@PEG composites
into fibrin-agarose (FA) hydrogels containing human oral
mucosa fibroblasts to obtain magnetic field-responsive tissue
substitutes.
Fibrin is a natural polymer frequently used in tissue engin-
eering. Combined with agarose, the biomechanical properties
of the resulting engineered tissues are considerably enhanced
and match the mechanical response of several native soft
human tissues.45–47 Furthermore, fibrin-agarose matrixes have
been successfully employed to generate substitutes of human
tissues such as the cornea, oral mucosa, skin and peripheral
nerves, which proved to be eﬀective in vivo.45,46,48 In our case,
the core–shell nanocomposites appeared homogeneously dis-
tributed over the network of fibrin fibers as shown by SEM
images (Fig. 5a). Interestingly, they frequently acted as connec-
tors between the fibrin fibers (see the inset of Fig. 5a). Very
likely, the negatively charged Poly@Mag@PEG nanocompo-
sites at physiological pH (zeta potential of −37.1 ± 0.8 mV at
pH = 7.4) attracted the positively charged E domains of fibrin
Fig. 4 Characterization of Poly@Mag@PEG composites. (a) Transmission electron microscopy picture of Poly@Mag@PEG composites. The PEG
coating appeared as a translucent thin ﬁlm around the magnetic shell in contrast to Poly@Mag composites with no PEG coating (inset). (b and c)
Macroscopic appearance of samples of Poly@Mag (b) and Poly@Mag@PEG (c) composites after 7 days of acid treatment. Poly@Mag@PEG compo-
sites remained magnetic because of the protective PEG layer. (d–g) Microscopy images of ﬁbroblasts. Those cultured in the presence of Poly@
Mag@PEG composites (g) showed an elongated shape identical to the shape of the ﬁbroblasts of the positive control (d). For Poly@Mag composites
(f ), some cells preserved the spindle shape, while others appeared more rounded like those of the negative control (e). (h) Quantiﬁcation of DNA
release after disintegration of the nuclear membrane. The core–shell nanocomposites (Poly@Mag and Poly@Mag@PEG) showed no signiﬁcant
diﬀerences with respect to the positive control. (i) Cell cytotoxicity results (WST-1 test). Samples with a greater number of viable cells displayed
stronger absorbance at 450–690 nm because of the formation of formazan. The number of viable cells was therefore smaller for Poly@Mag compo-
sites than for the positive control, while it remained approximately the same for Poly@Mag@PEG composites.
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monomers (generated after thrombin cleavage of the fibrino-
peptides of fibrinogen).49 The oxygen atoms of the PEG layer,
which can play the role of hydrogen bond acceptors,50 may
have formed hydrogen bonds with the hydrogen bond donors
of fibrin monomers. As a result, fibrin monomers anchored on
Poly@Mag@PEG composites, which acted as condensation
sites for the subsequent polymerization of fibrin fibers.
However, future investigations are needed to confirm these
hypotheses.
Cell morphology and proliferation in the magnetic tissue-
like constructs were normal as shown by histological analyses.
The engineered tissues with H&E showed a random distri-
bution of fibroblasts in the FA matrix (see Fig. 5b and S6 of the
ESI†). Interestingly, fibroblasts were found alone or forming
small cell clusters (see Fig. S6 of the ESI†), with prominent
nuclei in both cases. The nuclei of both individual and cluster-
forming fibroblasts showed intense positive immunoreaction
for PCNA immunohistochemical analysis (see Fig. 5c and S6 of
the ESI†), which confirmed the active proliferation of fibro-
blasts in the magnetic tissue substitutes. Fibroblasts preserved
their characteristic orthotopic elongated shape with large filo-
podia along the fibrin fibers as shown by SEM (Fig. 5a) and by
histological analyses (Fig. 5b–d and S6 of the ESI†), indicating
cell-biomaterial interactions. Although homogeneously distrib-
uted over the biopolymer, Poly@Mag@PEG composites were
frequently observed near the cell surface, around the peri-
nuclear cytoplasm and the large filopodia of the fibroblasts as
shown by the intense Prussian blue color of the composites
after staining with Perls’ histochemical method (see Fig. 5d
and S6 of the ESI†). Ex vivo Live/Dead™ assays revealed a high
number of metabolically active cells in the engineered tissues
containing Poly@Mag@PEG composites, which was similar to
the values observed for the fibrin-agarose control group (cellu-
lar construct without composites). In both cases, fluorescence
microscopy only showed live, green-stained, cells (dead cells
are stained with red color in this technique) as shown in
Fig. 5e. Remarkably, there were no statistically significant
diﬀerences (p > 0.05) between cell viability in the artificial
tissues prepared with Poly@Mag@PEG composites (98.3 ±
2.4%) and the fibrin-agarose control (98.1 ± 2.4%) (Fig. 5f),
Fig. 5 Characterization of magnetic tissue substitutes. (a) Scanning electron microscopy of ﬁbrin-agarose (FA) engineered tissue with Poly@Mag@
PEG nanostructures (bar length = 10 µm). As observed, the particles were homogeneously distributed over the network of ﬁbrin ﬁbres and the cells
maintained their orthotopic shape (the cell is indicated with an arrow). The insets allow better observation of the connection between the nano-
composites and ﬁbrin ﬁbres. (b–d) Ex vivo histological analysis of the magnetic tissues. H&E staining showed that the ﬁbroblasts were able to
acquire their typical elongated shape with prominent nuclei in the presence of the nanocomposites (b). PCNA immunohistochemical analysis
showed proliferating ﬁbroblasts (c) and Perl’s histochemical method speciﬁcally stained in blue the Poly@Mag@PEG composites. Black arrows
indicate the large ﬁlopodia of the ﬁbroblasts which interacted with some nanocomposites stained in blue (d). Scale bar = 5 µm. (e) Live/Dead™
ﬂuorescence microscopy images of a control artiﬁcial tissue of FA without nanocomposites (left image in (e)) and an engineered tissue with Poly@
Mag@PEG composites (right image in (e)). Fluorescent green color corresponds to live cells. Both samples exhibited identical appearance, with no
dead cells (red color). Scale bar = 100 µm. (f ) Quantiﬁcation of viable cells by the Live/Dead™ technique. There were no signiﬁcant diﬀerences in
the percentage of viable cells between the sample with Poly@Mag@PEG particles and the FA control sample.
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which demonstrated the high ex vivo biocompatibility of
Poly@Mag@PEG nanocomposites (Fig. 5f).
The incorporation of magnetic nanocomposites into the
artificial tissues transformed them into magnetic field-respon-
sive engineered tissues. Indeed, the engineered tissues pre-
pared with magnetic composites moved when exposed to the
magnetic field gradient created by a magnet (see Video 1 of
the ESI†). From magnetization measurements (see Fig. S7 of
the ESI†) we estimated the volume fraction of the magnetic
material in the engineered tissues, which turned out to be
∼0.3 vol%. Such a magnetized state of the engineered tissue
would allow attraction of functionalized MNPs carrying growth
factors, drugs or cells.11,17,22
In addition to field-responsiveness, the engineered tissues
showed magnetic field-tunable mechanical properties. More
specifically, we measured an increase of the storage modulus
(G′) of the engineered tissue of ∼10% when the intensity of the
external field was increased from 0 to 25.6 kA m−1 (Fig. 6a). G′
is connected to the elastic, solid-like, response of the bio-
material when subjected to an oscillatory mechanical stimulus,
and therefore, is a measure of its mechanical strength.51
Furthermore, the sole presence of the nanocomposites in the
fibrin network already increased the engineered tissue mech-
anical strength, even without magnetic field application. Actu-
ally, we observed a twofold increase of G′ for Poly@Mag@PEG
engineered tissues with respect to the FA control at zero field
(Fig. 6a). Such an increase was much higher than the one pre-
dicted by the classical theory of mechanics of composite
materials for a continuous matrix with spherical, completely
rigid inclusions,52 and could only be explained by microstruc-
tural changes in the pattern of the fibrin-agarose network due
to the Poly@Mag@PEG nanocomposites. As seen in Fig. 5a
and d, Poly@Mag@PEG composites were homogeneously dis-
tributed around the fibrin network and acted as connectors
between the fibrin fibers. This may have enhanced adhesion
between fibers and have had a failure retardation eﬀect which
could explain the higher values of G′ even in the absence of a
field.53 Similar increases with the field were obtained for the
loss modulus, G″, related to the dissipation of energy upon the
oscillatory mechanical stimulus (see Fig. S8 of the ESI†).51 The
increase of the viscoelastic moduli with the magnetic field was
maintained over a broad range of frequencies of the oscillatory
strain (see Fig. S9 of the ESI†). Although not huge, such an
increase proves that it is possible to control the mechanical
behavior of these artificial tissues by the application of an
external field. Stronger magnetic fields or higher composite
loadings would give rise to stronger mechanical changes.
However, the most interesting result here was the signifi-
cant enhancement of the mechanical properties when using
core–shell magnetic nanostructures in comparison with the
solid magnetic particles of similar size reported in ref. 30.
Indeed, a normalization of the field-induced increase of G′ by
the engineered tissue magnetic content, revealed a stronger
magnetic response for Poly@Mag@PEG nanocomposites
(Fig. 6b). Such an enhancement would be connected to the
improvement of the magnetic susceptibility in core–shell
nanostructures observed in Fig. 3. This latter result confirms
the excellent suitability of these composites to be used in the
preparation of novel magnetic tissue substitutes.
Time-dependent in vivo biocompatibility of Poly@Mag@PEG
composites and magnetic substitutes
We studied the time-dependent in vivo biocompatibility of free
(i.e., in suspension) Poly@Mag@PEG nanocomposites and of
Fig. 6 Mechanical properties of magnetic tissue substitutes. (a) Storage modulus, G’, as a function of the amplitude of the oscillatory strain for four
values of the applied magnetic ﬁeld, H (indicated). The mechanical strength of the engineered tissue increased with the magnetic ﬁeld as evidenced
by the increase of G’. (b) Normalization of the relative increment of G’ with the ﬁeld, [G’(H) − G’(0)]/G’(0), by the saturation magnetization of the
nanocomposites, Ms for engineered tissues consisting of Poly@Mag@PEG composites and solid magnetic particles of similar size (adapted from
M. T. Lopez-Lopez, G. Scionti, A. C. Oliveira, J. D. G. Duran, A. Campos, M. Alaminos and I. A. Rodriguez, PLoS One, 2015, 10, e013387830). As
observed, the increment with the ﬁeld is higher for core–shell nanostructures as a result of the enhancement of the initial magnetic susceptibility
observed in Fig. 3.
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the magnetic tissue-like constructs in the subcutaneous con-
nective tissue of the interscapular region of mice. The free
composites were suspended in physiological solution and were
carefully injected. The magnetic constructs were surgically
implanted. None of the animals died after 21 days in any of
the experimental groups. After 21 days the animals showed no
signs of side eﬀects and the changes of body weight were
similar to those of the control animals.
The subcutaneously injected Poly@Mag@PEG nanocompo-
sites remained in the interscapulum during the duration of
the experiment (i.e., 21 days), without migration to the distal
organs of the body. The injected nanocomposites formed an
irregular and dense mass consisting of nanocomposite aggre-
gates (Fig. 7b–g). The host response around this mass was a
moderate acute inflammatory reaction mainly composed
of neutrophils, some mononuclear cells and predominantly
macrophages (Fig. 7b–g). The inflammatory reaction was more
evident after the first week, but it progressively decreased from
the second to the third weeks. The inflammatory response was
only localized around the region where Poly@Mag@PEG com-
posites were injected. Cells progressively reabsorbed the mass
starting from the external part to the inner part. Perls’ staining
confirmed the presence of phagosomes with Poly@Mag@PEG
composites inside the macrophages (Fig. 7d and f) and the
picrosirius method revealed a progressive encapsulation of the
composite mass by a collagen-rich extracellular matrix and a
blood vessel network (Fig. 7c and e). The mass was not fully
reabsorbed after 21 days. The histological and histochemical
analyses of the liver, kidney, spleen and lungs did not show
any inflammatory reaction. There were no macrophages with
Poly@Mag@PEG composites inside either. Indeed, all organs
were histologically normal during the 21 day follow-up period
(Fig. 7n–q). Tissue samples taken from these organs did not
exhibit any magnetic response, in contrast to the samples
obtained from the interscapular region, which were magnetic
because of the presence of the nanocomposites (see Table S1
of the ESI†).
The histological analysis of the magnetic tissue-like con-
structs evidenced their successful subcutaneous implantation.
The constructs showed a regular and compacted morphology
(Fig. 7h–m). The nanocomposites appeared homogeneously
distributed over the thin FA hydrogel network, either individu-
ally or forming small aggregates, in contrast to the bigger
aggregates found when the nanocomposites were injected in
suspension (insets in Fig. 7c and i respectively). Therefore, the
FA hydrogel prevented from the aggregation of the nano-
composites and favored their consistent and homogeneous
individual distribution. The use of the FA hydrogel also eased
the interaction with the host tissue: host cells were able to
invade the implanted constructs from the first week (Fig. 7i
and inset), in contrast to the few cells observed in the case of
the injected nanocomposite suspension (Fig. 7c and inset).
The constructs were not fully reabsorbed after 21 days. The
host response to the constructs was a mild to moderate acute
inflammatory reaction which progressively decreased over time
(Fig. 7h–m). As in the case of the suspension of Poly@Mag@
PEG composites, a thin connective tissue capsule composed of
collagen fibers and a vascular network was formed around the
implants (Fig. 7k and m). The moderate local acute inflamma-
tory reaction did not aﬀect the surrounding connective tissues
and distal organs (Fig. 7h–m and r–u). Similarly to what hap-
pened to the nanocomposites in suspension, only the samples
from the interscapulum showed a magnetic response (see
Table S1 of the ESI†), which indicated no migration of the
Fig. 7 In vivo histological analyses. (a) Native skin control with normal
epidermis, dermis and hypodermis. (b–g) Tissue from the interscapulum
where Poly@Mag@PEG nanocomposites were injected after 1 week (b
and c) and 3 weeks (d–g) post injection. (h–m) Tissue from the inter-
scapulum where the magnetic tissue-like constructs were implanted
after 1 week (h and i) and 3 weeks ( j–m) post-surgical implantation. (b),
(d), (f ), (h), ( j) and (l) images show the Prussian blue histochemical reac-
tion for the Poly@Mag@PEG nanocomposites (Perl’s method). (c), (e),
(g), (i), (k) and (m) show picrosirius staining. (e) and (k) show the zone of
external degradation and capsule (stained in red with picrosirius). Note
the high number of cells in the magnetic engineered tissue after the ﬁrst
week (i and inset) in contrast with the injected nanocomposites (c and
the inset). Circles indicate macrophages with nanocomposites, and (*)
show small blood vessels in the newly-formed inﬂammatory capsule
after 3 weeks post in vivo implantation. (n–u) Tissues from distal organs
(liver, lung, spleen and kidney) of the experimental groups of injected
Poly@Mag@PEG nanocomposites (n–q) and the implanted magnetic
constructs (r–u) after 3 weeks. All organs were histologically normal
during the 21 day follow-up period.
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Poly@Mag@PEG composites to other organs during the
duration of the experiment.
Conclusions
In this work we have synthesized magnetic core–shell nano-
structures consisting of a polymeric (acrylic) core, a first shell
of magnetic iron oxide nanoparticles, and an additional layer
of polyethylene glycol (PEG). These composites have been
prepared with the aim of being used as the magnetic phase in
novel magnetic field-responsive tissue substitutes.
The prepared composites were uniform in size, the thick-
ness of the magnetic shell increasing with the concentration
of iron precursors in the co-precipitation reaction, which
allowed tuning of the magnetic properties. The core–shell
architecture improved the magnetic response of the compo-
sites with respect to solid magnetic particles of similar size.
More specifically, the magnetic susceptibility at low to
medium fields was higher, and increased when the magnetic
shell became thinner. In addition to enhanced magnetic pro-
perties, core–shell nanocomposites exhibited remarkably good
stability against gravitational settling because of the lower
density of the polymer core.
Because of the PEG outer layer, the nanocomposites exhibi-
ted excellent chemical stability and biocompatibility (i.e., no
significant cell damage and good cell growth and attachment).
For this reason, the composites were successfully loaded into
fibrin-agarose hydrogels containing human oral mucosa fibro-
blasts to obtain magnetic field-responsive engineered tissues
with metabolically active cells. The fibrin-agarose matrix pro-
moted the interaction with the host tissue when the magnetic
tissue-like constructs were implanted in vivo. It also prevented
colloidal aggregation of the nanocomposites, in contrast
to the situation when the nanocomposites were sub-
cutaneously injected in suspension. In both cases (i.e., implan-
tation and injection), there was only a localized and transitory
acute inflammatory reaction, without aﬀecting the distal
organs. Therefore, both the nanocomposites and the magnetic
engineered tissues showed good in vivo biocompatibility. After
21 days, the nanocomposites and the constructs were not fully
reabsorbed and still maintained their magnetic response.
Remarkably, we measured an enhancement of the artificial
tissue mechanical properties when exposed to an external
magnetic field. This latter result evidences the suitability of
these composites for being used in the preparation of new
engineered magnetic tissues whose mechanical properties can
be controlled by external, non-contact, forces. Future work will
focus on the functionalization of the nanocomposites for
specific purposes in regenerative medicine and tissue engin-
eering. The magnetic tissue-like constructs could be used for
cartilage tissue engineering (subjected to strong mechanical
forces at the joint surface) and for the generation of biodegrad-
able, functionalized, and mechanically stable tubes for peri-
pheral nerve repair. However, the use of these nanocomposites
should not only be restricted to tissue engineering, but could
also be extended to other applications such as smart magnetic
materials, biosensing and bioseparation, MRI, drug delivery or
hyperthermia. In addition, the inner core may provide func-
tionalities diﬀerent than those of the shell (e.g., attachment of
fluorescent molecules, proteins or drugs), which can be
beneficial for some of these applications.
Experimental
Preparation of Poly@Mag composites
The inner cores of the nanocomposites were PolymP–H par-
ticles kindly supplied by NanoMyP® (Spain). These particles
are monodisperse acrylic copolymer (methacrylic acid (MAA)
and ethylene glycol dimethacrylate (EDMA)) spheres, functio-
nalized with carboxylic groups (170 µmol COOH per g). The
chemicals used in the co-precipitation reaction (iron(III) chlor-
ide 6-hydrate; iron(II) sulphate 7-hydrate; ammonium hydr-
oxide, 28%) were purchased from Sigma-Aldrich (USA). The
water used in the diﬀerent steps of the syntheses was of
Milli-Q quality (Millipore, France).
The experimental procedure for preparing Poly@Mag par-
ticles was as follows: 50 mg of PolymP–H particles were dis-
persed in 3 mL of a 0.1 M aqueous solution of NH4OH to
promote deprotonation of the particle carboxylic groups and
to charge the surface of the particles negatively. After this step,
solutions of FeCl3·6H2O and FeSO4·7H2O with molar ratio
[Fe3+]/[Fe2+] = 0.5 were added, and the mixture was mechani-
cally stirred. We tested diﬀerent concentrations of iron ions to
determine how they aﬀected the final thickness of the mag-
netic layer. To allow co-precipitation of the iron hydroxides, a
solution of NH4OH (28%) was added until pH = 12 (a black
precipitate appeared). The mixture was aged for 1 hour under
strong mechanical stirring, followed by heating up to 95 °C to
promote magnetite formation. After cooling, the black precipi-
tate was magnetically separated and washed with distilled
water until neutral pH.
Preparation of Poly@Mag@PEG composites (polyethylene
glycol, PEG, coating)
To prepare Poly@Mag@PEG composites we employed the
method proposed by ref. 35 which is based on the formation
of an water-in-oil microemulsion. In the water phase (15 mL)
we dispersed 1 g of PEG (Mw = 400, Sigma-Aldrich, USA) and
0.3 g of Poly@Mag composites and ultrasonicated the sample
for 7 min. The oil phase consisted of 450 mL of n-hexane,
150 mL of mineral oil and 750 µL of sorbitan sesquioleate (sur-
factant), all from Sigma-Aldrich (USA). Both phases were then
mixed by ultrasonication for 5 min. Subsequently, 150 mL of
glutaraldehyde (Sigma-Aldrich, USA) were added and the
sample was stirred for 2 h. The product was finally separated
and washed with water and ethanol.
Physicochemical characterization of composites
Electron microscopy. We analyzed the morphology and
composition of the synthesized powders by scanning (SEM)
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and transmission (TEM) electron microscopy. We used
AURIGA (FIB-FESEM) and LIBRA 120 PLUS microscopes
respectively (both from Carl Zeiss GmbH, Germany). The
average diameter of the nanocomposites was the mean value
obtained by measuring particles from TEM pictures corres-
ponding to diﬀerent windows of the supporting grid. Energy-
dispersive X-ray (EDX) spectroscopy was also conducted.
X-ray diﬀraction (XRD). The bulk crystal structure of
Poly@Mag and Poly@Mag@PEG powders was analysed using
a D8 Advance powder diﬀractometer (Bruker, USA).
Thermogravimetric analysis (TGA). The loss of weight of the
composites when heated until 650 °C (heating rate of 20 °C
min−1) under a N2 atmosphere was measured with a TGA/
DSC1 thermogravimetric analyzer (METTLER-TOLEDO, USA).
Fourier transform infrared spectroscopy (FTIR). FTIR
spectra were recorded with a FP 6200 spectrophotometer
(JASCO, Japan). The samples were prepared using the KBr
pellet technique.
Analysis of gravitational settling. We scanned the temporal
reduction of absorbance connected to gravitational settling
using a UV–vis 8500 double-beam spectrophotometer (Dinko
Instruments, Spain). We used dilute samples and measured
the absorbance at λ = 590 nm for 24 h.
Chemical stability analysis. We evaluated the resistance of
Poly@Mag and Poly@Mag@PEG composites against acid
attack by dispersing them in a 0.1 M solution of HCl (Sigma-
Aldrich, USA). After 7 days we evaluated the magnetic response
of the composites by placing a neodymium magnet close to
the Eppendorf tubes containing the samples.
Magnetization measurements. The magnetization of the
obtained powders and of the engineered magnetic tissues was
measured at room temperature as a function of the magnetic
field strength in a vibrating sample magnetometer VSM 4500
(EG&G Princeton Applied Research, USA).
Zeta potential measurements. We measured the surface
charge of Poly@Mag@PEG nanocomposites at physiological
pH (i.e., pH = 7.4) using a Malvern Zetasizer (Nano ZS) instru-
ment. We injected dilute samples into a disposable cuvette
and the experiment was run at room temperature. We con-
ducted three runs per measurement. In each of the three
measurements we used freshly prepared samples.
Ethics statement
This study was approved by the Ethics Committee of the Uni-
versity of Granada, Granada, Spain. Each tissue donor for the
culture of fibroblasts signed an informed consent form for the
study. The in vivo characterization was performed following
the European Union and Spanish Government guidelines for
ethical care of animals (EU Directive no. 63/2010, RD 53/2013).
In vivo experiments were authorized by the Ethics Committee
of the University of Granada, Granada, Spain, in the framework
of the research project FIS PI14-1343.
Primary cultures of oral mucosa fibroblasts
Human oral mucosa fibroblasts were used for the biocompat-
ibility assays and the generation of magnetic bio-artificial
tissue-like constructs. Cells were isolated from 10 human oral
mucosa biopsies from healthy donors (School of Dental
Sciences, University of Granada) following previously described
procedures.30,54,55 Once in the laboratory, the biopsies were
mechanically fragmented and digested with 2 mg per mL of
Clostridium histolyticum collagenase I (Gibco BRL Life Techno-
logies, Karlsruhe, Germany). Fibroblasts were harvested by
centrifugation and cultured with an expansion medium (EM)
composed of Dulbecco’s modified Eagle’s medium (DMEM,
Sigma Aldrich, USA) supplemented with 10% foetal calf
serum (FCS) and 1% antibiotic–antimycotic cocktail solution
(100 U per ml of penicillin G, 100 mg per ml of streptomycin
and 0.25 mg per ml of amphotericin B; Sigma Aldrich,
Steinheim, Germany). Fibroblasts were incubated at 37 °C in
5% carbon dioxide (standard culture conditions), and EM was
renewed every 3 days. Fibroblasts were expanded by using
trypsin (Sigma-Aldrich, Steinheim, Germany) until the third
passage and used for the generation of the bio-artificial
constructs.
Cytotoxicity assays
We evaluated the ex vivo cell cytotoxicity of Poly@Mag and
Poly@Mag@PEG composites using a primary culture of
human gingival fibroblasts (24 wells per sample with a cell
density of 2 × 105 cells per 500 µl of DMEM). The cells were
exposed to 1 vol% of either Poly@Mag or Poly@Mag@PEG
composites for 24 h. In addition, cultures of fibroblasts
without any magnetic composites were used as positive con-
trols, and the cells treated with 2% Triton X-100 as the negative
control according to previous studies.30,45,54 The cell mor-
phology was analyzed by using a phase contrast microscope
(Nikon Eclipse Ti-U, Nikon, Japan) and NIS-Elements imaging
software (Nikon, Japan). The cell morphology was classified
into normal (elongated and spindle-shape) or aﬀected mor-
phology (irregular, rounded or apoptotic bodies) under each
experimental condition. Nuclear membrane permeability was
evaluated by the quantification of DNA release using spectro-
photometry (SmartSpec™ Plus, Bio-Rad, Hercules, CA, USA) at
λ = 260–280 nm. Finally, cell proliferation and viability were
measured by using the water-soluble tetrazolium salt-1
(WST-1) colorimetric assay (Cell Proliferation Reagent WST-1,
Roche Diagnostics). WST-1 is a tetrazolium dye containing an
electron coupling reagent that is cleaved by the mitochondrial
dehydrogenase enzyme to a formazan dye. The reaction
directly correlates with the number of metabolically active pro-
liferating cells and can serve as a marker of cell viability and
cell proliferation.
We report here the mean values ± standard deviations of 8
independent experiments for each experimental group and
each analysis. The Kruskal–Wallis test was used to identify stat-
istical diﬀerences among the study groups, and the Mann–
Whitney test was used to identify significant diﬀerences
between two groups. Values of p less than 0.05 were considered
statistically significant in two-tailed tests.
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Preparation of engineered magnetic tissues
The artificial magnetic tissues were generated based on the
use of fibrin-agarose hydrogels following a previously reported
protocol.45 Briefly, we used 3.8 mL of human plasma (obtained
from blood donors of the Health System Biobank of Granada,
Spain) and added 1 million of oral mucosa fibroblasts re-
suspended in 0.625 mL of DMEM together with 75 μL of a
solution of tranexamic acid at a concentration of 0.1 g mL−1
(final concentration of tranexamic acid in the biomaterial was
1.5 mg mL−1). Tranexamic acid is an anti-fibrinolytic agent
that prevents scaﬀold degradation. Afterwards, we added con-
centrated suspensions of Poly@Mag or Poly@Mag@PEG par-
ticles (previously sterilized by dispersion in 70% ethanol for
12 h) in DMEM to obtain a final concentration of composites
in the scaﬀold of approximately 1.1 vol%. Subsequently, we
added 0.25 mL of a mixture of type VII agarose (molecular
weight 120 000 g mol−1, Sigma Aldrich, USA) in PBS (0.02
g mL−1, Sigma-Aldrich, Steinheim, Germany) obtaining a 0.1%
final agarose concentration. Finally, we added 0.25 mL of
2% CaCl2 (Sigma Aldrich, USA) to the mixture to promote
polymerization of fibrin. The final solution was distributed in
6-well cell culture clusters (5 mL in each) and kept at 37 °C
until complete gelation. We applied a vertical magnetic field
(36 kA m−1) during the first 5 minutes of gelation with a coil.
After 2 hours we added EM to the constructs, and they were
kept under standard culture conditions for 24 h.
Structural analysis of the tissue substitutes
We analyzed the structure of magnetic tissue substitutes by
scanning electron microscopy (SEM). For this purpose, we
fixed the artificial tissues with 2.5% glutaraldehyde solution
and postfixed them in 1% osmium tetroxide for 90 min. Fixed
samples were dehydrated at increasing concentrations of
acetone, critical point-dried, mounted on aluminum stubs,
and sputter-coated with gold according to routine procedures.
Cell viability of the tissue substitutes
We evaluated cell cytotoxicity by analyzing the intracellular
esterase activity and the integrity of the plasma and nuclear
membranes. For this purpose, we employed the LIVE/DEAD™
(L/D) assay (Viability/Cytotoxicity kit; Molecular Probes, UK)
following the manufacturer’s guidelines. This method con-
tains Calcein-AM, which is metabolically modified by living
cells that emit green fluorescence, and ethidium homodimer-1,
which binds to the nuclei of dead cells emitting red fluo-
rescence. After 24 h of culture, small samples from each con-
struct were harvested, washed with PBS and incubated with
the LIVE/DEAD™ solution for 30 minutes. All images were
obtained and analyzed with a Nikon Eclipse 90i light and fluo-
rescence microscope (Nikon, Japan).
Histological analyses of the tissue substitutes
After 24 h of cell culture, all samples were fixed in 10%
buﬀered formalin for 24 h, dehydrated and embedded in
paraﬃn. We then cut the tissues in sections of 5 µm of thick-
ness. Histological sections were dewaxed, hydrated and
stained with hematoxylin–eosin (H&E) for morphological
evaluation. For the specific histochemical identification of the
magnetic nanocomposites (i.e., identification of ferric iron),
the sections were stained with Perl’s histochemical method
(PERLS) (Prussian blue reaction).56 In order to obtain an over-
view of the tissue, Perl’s method was slightly contrasted with
H&E. We also studied the active proliferation of fibroblasts
by identification of the proliferating cell nuclear antigen
(PCNA) by indirect immunohistochemistry as previously
described.57,58 Briefly, for immunohistochemistry, the tissue
sections were dewaxed, hydrated and pretreated for antigen
unmasking (citrate buﬀer pH = 6). Endogenous peroxidase
activity was blocked with 3% (v/v) H2O2 in 0.1 M PBS, and the
nonspecific binding of the primary antibody was blocked
using casein solution (Vector, Burlingame, CA, USA). After
that, the sections were incubated with the primary antibody
Mouse anti-PCNA (clone PC10, Sigma Aldrich, Steinheim,
Germany) 1 : 1000 in PBS tween-20 for 1 hour at room tempera-
ture. Sections were abundantly rinsed with PBS and then incu-
bated with a Horse anti-mouse IgG conjugated with peroxidase
(Vector, Burlingame, CA, USA). Finally, the antigen-antibody
reaction was visualized with diaminobenzidine (DAB) (Vector,
Burlingame, CA, USA) and contrasted with Mayer hematoxylin.
In addition, the primary antibody was omitted in parallel
slides as a technical negative control.
Rheological characterization of engineered magnetic tissues
We measured the mechanical properties of tissue substitutes
at 37 °C using a Haake MARS III (Thermo Fisher Scientific,
USA) controlled stress rheometer. We employed a measuring
set of non-magnetic parallel plates (diameter of 3.5 cm) with
rough surfaces to avoid wall slip. We applied a vertical mag-
netic field (i.e., in the direction of the rheometer axis) using a
homemade coil. The magnetic field was switched on 1 minute
before each test. We placed the engineered tissues on the
lower plate of the rheometer and squeezed them with the
upper plate until a fixed gap of 300 μm.
We conducted two types of oscillatory shear tests. (i) Ampli-
tude sweep tests: we fixed the frequency, f = 1 Hz, of the oscil-
latory strain, γ = γ0 cos(2πft ) and increased the strain
amplitude, γ0, in a logarithmic ramp. The sinusoidal strain at
each step was applied over 8 periods of oscillations. We
recorded the resulting viscoelastic moduli (i.e., the storage, G′,
and loss, G″, moduli) over the last 5 periods to discard transi-
ents. (ii) Frequency sweep tests: we fixed γ0 at a value belong-
ing to the viscoelastic linear region (i.e., the region for which
the viscoelastic moduli are independent of γ0) and varied f.
Again, we maintained the oscillatory strain for 8 periods and
recorded the last 5. The obtained values for all the quantities
in this work are the average of at least 3 repetitions.
In vivo evaluation of Poly@Mag@PEG composites and of the
engineered magnetic tissues
Laboratory animals and experimental groups. For the in vivo
assays of this work, 9-week-old male mice (Mus Musculus) were
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provided by and maintained in the Experimental Unit of the
University Hospital “Virgen de las Nieves” (Granada, Spain).
The animals were deeply anaesthetized by intraperitoneal
injection of a mixture of acepromizine (Calmo-Neosan®,
0.001 mg per g of weight of the animal) and ketamine
(Imalgene 1000®, 0.15 mg per g of weight of the animal) after
subcutaneous administration of atropine. The 27 provided
animals were randomly assigned to the following three experi-
mental groups (n = 9 in each):
(i) in vivo kinetic evaluation of Poly@Mag@PEG nano-
composites (S-PMPc). We evaluated the time-dependent bio-
distribution and biocompatibility of the Poly@Mag@PEG
composites by subcutaneously injecting 500 µl of a sterile
physiological suspension of the composites of concentration
11 mg mL−1 in the interscapulum of each mouse.
(ii) In vivo kinetic evaluation of engineered magnetic tissue
(FA-PMPc). We evaluated the time-dependent biocompatibility
of the engineered magnetic tissues by a subcutaneous implan-
tation of a 500 µl construct (concentration of 11 mg mL−1) in
the interscapulum.
(iii) Control group (CTR) of healthy animals without any
surgical intervention.
After injection or subcutaneous implantation of the con-
structs, all the animals were housed in a temperature-
controlled room (21 ± 1 °C), provided with a 12 h light/dark
cycle and ad libitum access to tap water and standard mice
chow.
The in vivo histological biocompatibility was studied after 7,
14 and 21 days (3 mice of each group were analyzed each week,
n = 3). Animals of each experimental group were euthanized by
cervical dislocation and the interscapulum (skin with hypo-
dermis), liver, kidneys, spleen and lungs were harvested for
tissue processing and histological analyses.
Histological analyses. All samples were fixed in 10%
buﬀered formalin for 24 h, dehydrated and embedded in
paraﬃn and divided into sections of 5 µm of thickness. Histo-
logical sections were dewaxed, hydrated and stained with
hematoxylin–eosin (H&E) for morphological evaluation and/or
pathological evaluations. All the samples were stained using
the picrosirius method which is highly specific for the evalu-
ation of the collagen extracellular matrix.59 In addition, we
used the periodic acid-Schiﬀ (PAS) histochemical method to
evaluate the glycogen content of the liver (indicator of the
normal function of this organ), the basal membrane of the
kidneys (indicator of the normal structure of these organs) and
the basal membrane and reticular fibers of the other tissues
and organs. For the identification of Poly@Mag@PEG nano-
composites, all the tissues and organs were stained with Perls’
method (described above).
Evaluation of the magnetic response of organ samples. We
took samples from the area of injection/implantation, spleen,
liver, lungs and kidneys and evaluated their magnetic response
to identify the presence of Poly@Mag@PEG composites. For
this purpose, we placed the samples near a neodymium
magnet providing a magnetic field gradient of 10 mT mm−1
and a maximum field of 470 mT, and observed the magnetic
field-induced migration of the composites towards the areas of
stronger field.
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